Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Takeda Tightens Belt As It Anticipates Difficult 2024, With Growth Returning After

09 May 2024

• By Alaric DeArment

• Source: Shutterstock

Related Content

A Month After Lung Cancer Withdrawal, Takeda Gets Approval For New Colorectal Cancer Drug

09 Nov 2023

Takeda Will Take TYK2 Inhibitor Into Phase III, Looks For Dosing Edge Over BMS Rival

08 Nov 2023

Takeda Charges Into Diversification With ITP Win

13 Mar 2024

Takeda Gets FDA Nod For HyQvia In CIDP

16 Jan 2024

Takeda Hits Accelerator On TAK-861 After Phase II Narcolepsy Win

09 Feb 2024

Related Companies

Takeda Pharmaceutical Co. Ltd.

Nimbus Therapeutics, Inc.

Bristol Myers Squibb Company

Additional Topics

Sales & Earnings Business Strategies Restructuring Commercial BioPharmaceutical

More from Earnings

More from Business

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.